Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

Burden of disease associated with human cytomegalovirus and prospects for elimination by universal immunisation.

Griffiths PD.

Lancet Infect Dis. 2012 Oct;12(10):790-8. doi: 10.1016/S1473-3099(12)70197-4. Epub 2012 Sep 24. Review.

PMID:
23017365
2.

Prospects of a vaccine for the prevention of congenital cytomegalovirus disease.

Plachter B.

Med Microbiol Immunol. 2016 Dec;205(6):537-547. Epub 2016 Aug 12. Review.

PMID:
27519596
3.

Could therapeutic vaccination of cytomegalovirus-seropositive persons prevent reinfection and congenital virus transmission?

Schleiss MR.

J Infect Dis. 2011 Jun 1;203(11):1513-6. doi: 10.1093/infdis/jir144. No abstract available.

4.

Development of cytomegalovirus vaccines: prospects for prevention of congenital CMV infection.

Pass RF, Burke RL.

Semin Pediatr Infect Dis. 2002 Jul;13(3):196-204. Review.

PMID:
12199616
5.

Vaccine strategies against human cytomegalovirus infection.

Zhong J, Khanna R.

Expert Rev Anti Infect Ther. 2007 Jun;5(3):449-59. Review.

PMID:
17547509
6.

Immunity induced by primary human cytomegalovirus infection protects against secondary infection among women of childbearing age.

Adler SP, Starr SE, Plotkin SA, Hempfling SH, Buis J, Manning ML, Best AM.

J Infect Dis. 1995 Jan;171(1):26-32. Erratum in: J Infect Dis 1995 Apr;171(4):1080.

PMID:
7798679
7.

Epidemiology, pathogenesis and prevention of congenital cytomegalovirus infection.

Burny W, Liesnard C, Donner C, Marchant A.

Expert Rev Anti Infect Ther. 2004 Dec;2(6):881-94. Review.

PMID:
15566332
8.

Recent approaches and strategies in the generation of antihuman cytomegalovirus vaccines.

Boppana SB, Britt WJ.

Methods Mol Biol. 2014;1119:311-48. doi: 10.1007/978-1-62703-788-4_17.

PMID:
24639230
9.

Cytomegalovirus Vaccines: Current Status and Future Prospects.

Anderholm KM, Bierle CJ, Schleiss MR.

Drugs. 2016 Nov;76(17):1625-1645. Review.

PMID:
27882457
10.

Clinical aspects and management of cytomegalovirus infection.

Sissons JG, Carmichael AJ.

J Infect. 2002 Feb;44(2):78-83. Review.

PMID:
12076065
11.

Recent advances in designing an effective vaccine to prevent cytomegalovirus-associated clinical diseases.

Dasari V, Smith C, Khanna R.

Expert Rev Vaccines. 2013 Jun;12(6):661-76. doi: 10.1586/erv.13.46. Review.

PMID:
23750795
12.

[Cytomegalovirus, pregnancy and occupational risk].

Boussemart T, Baudon JJ, Garbarg-Chenon A, Costil J.

Arch Pediatr. 1998 Jan;5(1):24-6. French.

PMID:
10223107
13.

[Cytomegalovirus infection in pregnancy].

Pusztai R.

Orv Hetil. 2009 May 24;150(21):963-8. doi: 10.1556/OH.2009.28614. Review. Hungarian.

PMID:
19443304
14.

Development of a cytomegalovirus vaccine: lessons from recent clinical trials.

Gonczol E, Plotkin S.

Expert Opin Biol Ther. 2001 May;1(3):401-12. Review.

PMID:
11727514
15.

Encouraging prospects for immunisation against primary cytomegalovirus infection.

Griffiths PD, McLean A, Emery VC.

Vaccine. 2001 Jan 8;19(11-12):1356-62.

PMID:
11163656
16.

The pathogenesis of human cytomegalovirus.

Griffiths P, Baraniak I, Reeves M.

J Pathol. 2015 Jan;235(2):288-97. doi: 10.1002/path.4437. Review.

PMID:
25205255
17.

Progress toward an elusive goal: current status of cytomegalovirus vaccines.

Schleiss MR, Heineman TC.

Expert Rev Vaccines. 2005 Jun;4(3):381-406. Review.

PMID:
16026251
18.

Postnatal cytomegalovirus: innocent bystander or hidden problem?

Luck S, Sharland M.

Arch Dis Child Fetal Neonatal Ed. 2009 Jan;94(1):F58-64. doi: 10.1136/adc.2007.131623. Epub 2008 Oct 6. Review.

PMID:
18838466
19.

[Is maternal infection with cytomegalovirus prevention possible?].

Cordier AG, Vauloup-Fellous C, Picone O.

Gynecol Obstet Fertil. 2010 Oct;38(10):620-3. doi: 10.1016/j.gyobfe.2010.07.016. Epub 2010 Sep 29. French.

PMID:
20884272
20.

CMV vaccine trial endpoints.

Griffiths PD.

J Clin Virol. 2009 Dec;46 Suppl 4:S64-7. doi: 10.1016/j.jcv.2009.10.003. Epub 2009 Oct 30.

PMID:
19879802

Supplemental Content

Support Center